HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic utility of glycosyltransferase expression in breast cancer.

AbstractBACKGROUND:
The post-translational modification of proteins, including glycosylation, is known to differ between normal and tumour cells. In this study, the expression profile of two glycosyltranferases, UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 (ppGalNAc-T6) and alpha6-sialyl-transferase-I (ST6GalNAc-I) was assessed, in a cohort of women with breast cancer.
PATIENTS AND METHODS:
Breast cancer tissues (n=127) and normal background tissues (n=33) were collected immediately after excision during surgery. Following RNA extraction, reverse transcription was carried out and transcript levels were determined using real-time quantitative PCR and normalized against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression. Transcript levels within the breast cancer specimens were compared to the normal background tissues and analyzed against conventional pathological parameters and clinical outcome over a 10 year follow-up period.
RESULTS:
Significantly higher levels of ppGalNAc-T6 were found in the breast cancer specimens compared to the background tissue (p=0.015). There was a non-significant trend for levels to increase with the Nottingham Prognostic Index (NPI) and TNM stage and those who died from breast cancer. ST6GalNAc-I expression was associated with better prognosis, reaching significance when comparing patients who remained disease free to those with distant recurrence (p=0.0096). The relationship approached significance when comparing NPI 2 to NPI 3 (p=0.058) and disease free patients to non-disease free patients (p=0.052) or those who died of breast cancer (p=0.060). For both enzymes a significant association with ductal type was found.
CONCLUSION:
Expression of ppGalNAc-T6 is significantly higher in breast cancer compared to 'normal'/benign breast tissue samples. ST6GalNAc-I expression in breast cancer is associated with better prognosis.
AuthorsNeill Patani, Wen Jiang, Kefah Mokbel
JournalCancer genomics & proteomics (Cancer Genomics Proteomics) 2008 Nov-Dec Vol. 5 Issue 6 Pg. 333-40 ISSN: 1109-6535 [Print] Greece
PMID19287074 (Publication Type: Journal Article)
Chemical References
  • Neoplasm Proteins
  • N-Acetylgalactosaminyltransferases
  • UDP-N-acetylgalactosamine polypeptide N-acetylgalactosaminyltransferase 6
  • Sialyltransferases
  • beta-D-Galactoside alpha 2-6-Sialyltransferase
Topics
  • Breast Neoplasms (enzymology, mortality)
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Gene Expression Regulation, Enzymologic
  • Gene Expression Regulation, Neoplastic
  • Humans
  • N-Acetylgalactosaminyltransferases (biosynthesis)
  • Neoplasm Proteins (biosynthesis)
  • Predictive Value of Tests
  • Sialyltransferases (biosynthesis)
  • Survival Rate
  • beta-D-Galactoside alpha 2-6-Sialyltransferase

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: